axforpharma

axforpharma shows an inactive EU-US Data Privacy Framework status as of 12 Oct 2026. The registry record lists an original issuance date of 15 Jan 2019, with no active expiration date and the status recorded as expired. No subsequent re-certification under the EU-US Data Privacy Framework is reflected in the evidence as of 12 Oct 2026. For other frameworks typically reviewed in vendor risk assessments, including SOC 2, PCI DSS, FedRAMP, and HIPAA, no public evidence found as of 12 Oct 2026. Reviewers should note the expired EU-US Data Privacy Framework status when assessing this vendor's cross-border data handling practices.

• EU-US Data Privacy Framework: expired, originally issued 15 Jan 2019, status inactive as of 12 Oct 2026
• No active data transfer framework registry listing found as of 12 Oct 2026
• No public evidence found for SOC 2, PCI DSS, FedRAMP, or HIPAA as of 12 Oct 2026

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 18 Oct 2026; it is regenerated whenever a row changes.